Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.
Identifieur interne : 000336 ( Main/Exploration ); précédent : 000335; suivant : 000337Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.
Auteurs : Angel Vila-Corcoles [Espagne] ; Olga Ochoa-Gondar ; Teresa Rodriguez-Blanco ; Antonia Gutierrez-Perez ; Angel Vila-Rovira ; Frederic Gomez ; Xavier Raga ; Cinta De Diego ; Eva Satue ; Elisabet SalsenchSource :
- BMC public health [ 1471-2458 ] ; 2012.
Descripteurs français
- KwdFr :
- Encéphalopathie ischémique (prévention et contrôle), Encéphalopathie ischémique (épidémiologie), Espagne (MeSH), Femelle (MeSH), Hospitalisation (statistiques et données numériques), Humains (MeSH), Infarctus du myocarde (diagnostic), Infarctus du myocarde (prévention et contrôle), Infarctus du myocarde (épidémiologie), Infections communautaires (prévention et contrôle), Infections communautaires (épidémiologie), Maladie aigüe (MeSH), Mâle (MeSH), Pneumonie à pneumocoques (prévention et contrôle), Pneumonie à pneumocoques (épidémiologie), Pneumopathie infectieuse (prévention et contrôle), Pneumopathie infectieuse (épidémiologie), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Surveillance de la population (MeSH), Systèmes informatisés de dossiers médicaux (MeSH), Vaccination (statistiques et données numériques), Vaccins antipneumococciques (administration et posologie), Études de cohortes (MeSH), Études de suivi (MeSH), Études prospectives (MeSH).
- MESH :
- administration et posologie : Vaccins antipneumococciques.
- diagnostic : Infarctus du myocarde.
- prévention et contrôle : Encéphalopathie ischémique, Infarctus du myocarde, Infections communautaires, Pneumonie à pneumocoques, Pneumopathie infectieuse.
- statistiques et données numériques : Hospitalisation, Vaccination.
- épidémiologie : Encéphalopathie ischémique, Infarctus du myocarde, Infections communautaires, Pneumonie à pneumocoques, Pneumopathie infectieuse.
- Espagne, Femelle, Humains, Maladie aigüe, Mâle, Résultat thérapeutique, Sujet âgé, Surveillance de la population, Systèmes informatisés de dossiers médicaux, Études de cohortes, Études de suivi, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Acute Disease (MeSH), Aged (MeSH), Brain Ischemia (epidemiology), Brain Ischemia (prevention & control), Cohort Studies (MeSH), Community-Acquired Infections (epidemiology), Community-Acquired Infections (prevention & control), Female (MeSH), Follow-Up Studies (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Male (MeSH), Medical Records Systems, Computerized (MeSH), Myocardial Infarction (diagnosis), Myocardial Infarction (epidemiology), Myocardial Infarction (prevention & control), Pneumococcal Vaccines (administration & dosage), Pneumonia (epidemiology), Pneumonia (prevention & control), Pneumonia, Pneumococcal (epidemiology), Pneumonia, Pneumococcal (prevention & control), Population Surveillance (MeSH), Prospective Studies (MeSH), Spain (MeSH), Treatment Outcome (MeSH), Vaccination (statistics & numerical data).
- MESH :
- chemical , administration & dosage : Pneumococcal Vaccines.
- geographic : Spain.
- diagnosis : Myocardial Infarction.
- epidemiology : Brain Ischemia, Community-Acquired Infections, Myocardial Infarction, Pneumonia, Pneumonia, Pneumococcal.
- prevention & control : Brain Ischemia, Community-Acquired Infections, Myocardial Infarction, Pneumonia, Pneumonia, Pneumococcal.
- statistics & numerical data : Hospitalization, Vaccination.
- Acute Disease, Aged, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Medical Records Systems, Computerized, Population Surveillance, Prospective Studies, Treatment Outcome.
Abstract
BACKGROUND
Conflicting results have been recently reported evaluating the relationship between pneumococcal vaccination and the risk of thrombotic vascular events. This study assessed the clinical effectiveness of the 23-valent polysaccharide pneumococcal vaccine (PPV23) against acute myocardial infarction and ischaemic stroke in older adults.
METHODS
Population-based prospective cohort study conducted from December 1, 2008 until November 30, 2009, including all individuals ≥ 60 years-old assigned to nine Primary Care Centres in Tarragona, Spain (N = 27,204 individuals). Primary outcomes were hospitalisation for acute myocardial infarction and/or ischaemic stroke. All cases were validated by checking clinical records. The association between pneumococcal vaccination and the risk of each outcome was evaluated by Multivariable Cox proportional-hazard models (adjusted by age, sex, influenza vaccine status, presence of comorbidities and cardiovascular risk factors).
RESULTS
Cohort members were followed for a total of 26,444 person-years, of which 34% were for vaccinated subjects. Overall incidence rates (per 1000 person-years) were 4.9 for myocardial infarction and 4.6 for ischaemic stroke. In the multivariable analysis, vaccination was associated with a marginally significant 35% lower risk of stroke (hazard ratio [HR]: 0.65; 95% confidence interval [CI]: 0.42-0.99; p = 0.046). We found no evidence for an association between pneumococcal vaccination and reduced risk of myocardial infarction (HR: 0.83; 95% CI: 0.56-1.22; p = 0.347).
CONCLUSIONS
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events.
DOI: 10.1186/1471-2458-12-222
PubMed: 22436146
PubMed Central: PMC3331814
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.</title><author><name sortKey="Vila Corcoles, Angel" sort="Vila Corcoles, Angel" uniqKey="Vila Corcoles A" first="Angel" last="Vila-Corcoles">Angel Vila-Corcoles</name><affiliation wicri:level="1"><nlm:affiliation>Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catalá de la Salut, Tarragona, Spain. avila.tarte.ics@gencat.cat</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catalá de la Salut, Tarragona</wicri:regionArea><wicri:noRegion>Tarragona</wicri:noRegion></affiliation></author><author><name sortKey="Ochoa Gondar, Olga" sort="Ochoa Gondar, Olga" uniqKey="Ochoa Gondar O" first="Olga" last="Ochoa-Gondar">Olga Ochoa-Gondar</name></author><author><name sortKey="Rodriguez Blanco, Teresa" sort="Rodriguez Blanco, Teresa" uniqKey="Rodriguez Blanco T" first="Teresa" last="Rodriguez-Blanco">Teresa Rodriguez-Blanco</name></author><author><name sortKey="Gutierrez Perez, Antonia" sort="Gutierrez Perez, Antonia" uniqKey="Gutierrez Perez A" first="Antonia" last="Gutierrez-Perez">Antonia Gutierrez-Perez</name></author><author><name sortKey="Vila Rovira, Angel" sort="Vila Rovira, Angel" uniqKey="Vila Rovira A" first="Angel" last="Vila-Rovira">Angel Vila-Rovira</name></author><author><name sortKey="Gomez, Frederic" sort="Gomez, Frederic" uniqKey="Gomez F" first="Frederic" last="Gomez">Frederic Gomez</name></author><author><name sortKey="Raga, Xavier" sort="Raga, Xavier" uniqKey="Raga X" first="Xavier" last="Raga">Xavier Raga</name></author><author><name sortKey="De Diego, Cinta" sort="De Diego, Cinta" uniqKey="De Diego C" first="Cinta" last="De Diego">Cinta De Diego</name></author><author><name sortKey="Satue, Eva" sort="Satue, Eva" uniqKey="Satue E" first="Eva" last="Satue">Eva Satue</name></author><author><name sortKey="Salsench, Elisabet" sort="Salsench, Elisabet" uniqKey="Salsench E" first="Elisabet" last="Salsench">Elisabet Salsench</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22436146</idno><idno type="pmid">22436146</idno><idno type="doi">10.1186/1471-2458-12-222</idno><idno type="pmc">PMC3331814</idno><idno type="wicri:Area/Main/Corpus">00310</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00310</idno><idno type="wicri:Area/Main/Curation">000310</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000310</idno><idno type="wicri:Area/Main/Exploration">000310</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.</title><author><name sortKey="Vila Corcoles, Angel" sort="Vila Corcoles, Angel" uniqKey="Vila Corcoles A" first="Angel" last="Vila-Corcoles">Angel Vila-Corcoles</name><affiliation wicri:level="1"><nlm:affiliation>Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catalá de la Salut, Tarragona, Spain. avila.tarte.ics@gencat.cat</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catalá de la Salut, Tarragona</wicri:regionArea><wicri:noRegion>Tarragona</wicri:noRegion></affiliation></author><author><name sortKey="Ochoa Gondar, Olga" sort="Ochoa Gondar, Olga" uniqKey="Ochoa Gondar O" first="Olga" last="Ochoa-Gondar">Olga Ochoa-Gondar</name></author><author><name sortKey="Rodriguez Blanco, Teresa" sort="Rodriguez Blanco, Teresa" uniqKey="Rodriguez Blanco T" first="Teresa" last="Rodriguez-Blanco">Teresa Rodriguez-Blanco</name></author><author><name sortKey="Gutierrez Perez, Antonia" sort="Gutierrez Perez, Antonia" uniqKey="Gutierrez Perez A" first="Antonia" last="Gutierrez-Perez">Antonia Gutierrez-Perez</name></author><author><name sortKey="Vila Rovira, Angel" sort="Vila Rovira, Angel" uniqKey="Vila Rovira A" first="Angel" last="Vila-Rovira">Angel Vila-Rovira</name></author><author><name sortKey="Gomez, Frederic" sort="Gomez, Frederic" uniqKey="Gomez F" first="Frederic" last="Gomez">Frederic Gomez</name></author><author><name sortKey="Raga, Xavier" sort="Raga, Xavier" uniqKey="Raga X" first="Xavier" last="Raga">Xavier Raga</name></author><author><name sortKey="De Diego, Cinta" sort="De Diego, Cinta" uniqKey="De Diego C" first="Cinta" last="De Diego">Cinta De Diego</name></author><author><name sortKey="Satue, Eva" sort="Satue, Eva" uniqKey="Satue E" first="Eva" last="Satue">Eva Satue</name></author><author><name sortKey="Salsench, Elisabet" sort="Salsench, Elisabet" uniqKey="Salsench E" first="Elisabet" last="Salsench">Elisabet Salsench</name></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease (MeSH)</term><term>Aged (MeSH)</term><term>Brain Ischemia (epidemiology)</term><term>Brain Ischemia (prevention & control)</term><term>Cohort Studies (MeSH)</term><term>Community-Acquired Infections (epidemiology)</term><term>Community-Acquired Infections (prevention & control)</term><term>Female (MeSH)</term><term>Follow-Up Studies (MeSH)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Medical Records Systems, Computerized (MeSH)</term><term>Myocardial Infarction (diagnosis)</term><term>Myocardial Infarction (epidemiology)</term><term>Myocardial Infarction (prevention & control)</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Pneumonia (epidemiology)</term><term>Pneumonia (prevention & control)</term><term>Pneumonia, Pneumococcal (epidemiology)</term><term>Pneumonia, Pneumococcal (prevention & control)</term><term>Population Surveillance (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Spain (MeSH)</term><term>Treatment Outcome (MeSH)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Encéphalopathie ischémique (prévention et contrôle)</term><term>Encéphalopathie ischémique (épidémiologie)</term><term>Espagne (MeSH)</term><term>Femelle (MeSH)</term><term>Hospitalisation (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Infarctus du myocarde (diagnostic)</term><term>Infarctus du myocarde (prévention et contrôle)</term><term>Infarctus du myocarde (épidémiologie)</term><term>Infections communautaires (prévention et contrôle)</term><term>Infections communautaires (épidémiologie)</term><term>Maladie aigüe (MeSH)</term><term>Mâle (MeSH)</term><term>Pneumonie à pneumocoques (prévention et contrôle)</term><term>Pneumonie à pneumocoques (épidémiologie)</term><term>Pneumopathie infectieuse (prévention et contrôle)</term><term>Pneumopathie infectieuse (épidémiologie)</term><term>Résultat thérapeutique (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Surveillance de la population (MeSH)</term><term>Systèmes informatisés de dossiers médicaux (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antipneumococciques (administration et posologie)</term><term>Études de cohortes (MeSH)</term><term>Études de suivi (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infarctus du myocarde</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Brain Ischemia</term><term>Community-Acquired Infections</term><term>Myocardial Infarction</term><term>Pneumonia</term><term>Pneumonia, Pneumococcal</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Brain Ischemia</term><term>Community-Acquired Infections</term><term>Myocardial Infarction</term><term>Pneumonia</term><term>Pneumonia, Pneumococcal</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Encéphalopathie ischémique</term><term>Infarctus du myocarde</term><term>Infections communautaires</term><term>Pneumonie à pneumocoques</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Encéphalopathie ischémique</term><term>Infarctus du myocarde</term><term>Infections communautaires</term><term>Pneumonie à pneumocoques</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Aged</term><term>Cohort Studies</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Medical Records Systems, Computerized</term><term>Population Surveillance</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Espagne</term><term>Femelle</term><term>Humains</term><term>Maladie aigüe</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Surveillance de la population</term><term>Systèmes informatisés de dossiers médicaux</term><term>Études de cohortes</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Conflicting results have been recently reported evaluating the relationship between pneumococcal vaccination and the risk of thrombotic vascular events. This study assessed the clinical effectiveness of the 23-valent polysaccharide pneumococcal vaccine (PPV23) against acute myocardial infarction and ischaemic stroke in older adults.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Population-based prospective cohort study conducted from December 1, 2008 until November 30, 2009, including all individuals ≥ 60 years-old assigned to nine Primary Care Centres in Tarragona, Spain (N = 27,204 individuals). Primary outcomes were hospitalisation for acute myocardial infarction and/or ischaemic stroke. All cases were validated by checking clinical records. The association between pneumococcal vaccination and the risk of each outcome was evaluated by Multivariable Cox proportional-hazard models (adjusted by age, sex, influenza vaccine status, presence of comorbidities and cardiovascular risk factors).</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Cohort members were followed for a total of 26,444 person-years, of which 34% were for vaccinated subjects. Overall incidence rates (per 1000 person-years) were 4.9 for myocardial infarction and 4.6 for ischaemic stroke. In the multivariable analysis, vaccination was associated with a marginally significant 35% lower risk of stroke (hazard ratio [HR]: 0.65; 95% confidence interval [CI]: 0.42-0.99; p = 0.046). We found no evidence for an association between pneumococcal vaccination and reduced risk of myocardial infarction (HR: 0.83; 95% CI: 0.56-1.22; p = 0.347).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22436146</PMID><DateCompleted><Year>2012</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2012</Year><Month>Mar</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.</ArticleTitle><Pagination><MedlinePgn>222</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2458-12-222</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Conflicting results have been recently reported evaluating the relationship between pneumococcal vaccination and the risk of thrombotic vascular events. This study assessed the clinical effectiveness of the 23-valent polysaccharide pneumococcal vaccine (PPV23) against acute myocardial infarction and ischaemic stroke in older adults.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Population-based prospective cohort study conducted from December 1, 2008 until November 30, 2009, including all individuals ≥ 60 years-old assigned to nine Primary Care Centres in Tarragona, Spain (N = 27,204 individuals). Primary outcomes were hospitalisation for acute myocardial infarction and/or ischaemic stroke. All cases were validated by checking clinical records. The association between pneumococcal vaccination and the risk of each outcome was evaluated by Multivariable Cox proportional-hazard models (adjusted by age, sex, influenza vaccine status, presence of comorbidities and cardiovascular risk factors).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Cohort members were followed for a total of 26,444 person-years, of which 34% were for vaccinated subjects. Overall incidence rates (per 1000 person-years) were 4.9 for myocardial infarction and 4.6 for ischaemic stroke. In the multivariable analysis, vaccination was associated with a marginally significant 35% lower risk of stroke (hazard ratio [HR]: 0.65; 95% confidence interval [CI]: 0.42-0.99; p = 0.046). We found no evidence for an association between pneumococcal vaccination and reduced risk of myocardial infarction (HR: 0.83; 95% CI: 0.56-1.22; p = 0.347).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vila-Corcoles</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catalá de la Salut, Tarragona, Spain. avila.tarte.ics@gencat.cat</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochoa-Gondar</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Rodriguez-Blanco</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Gutierrez-Perez</LastName><ForeName>Antonia</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Vila-Rovira</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Frederic</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Raga</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>de Diego</LastName><ForeName>Cinta</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Satue</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Salsench</LastName><ForeName>Elisabet</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><CollectiveName>EPIVAC Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C414006">23-valent pneumococcal capsular polysaccharide vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016347" MajorTopicYN="N">Medical Records Systems, Computerized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011018" MajorTopicYN="N">Pneumonia, Pneumococcal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>10</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>03</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22436146</ArticleId><ArticleId IdType="pii">1471-2458-12-222</ArticleId><ArticleId IdType="doi">10.1186/1471-2458-12-222</ArticleId><ArticleId IdType="pmc">PMC3331814</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stroke. 2006 Feb;37(2):577-617</Citation><ArticleIdList><ArticleId IdType="pubmed">16432246</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2004 Dec 16;351(25):2611-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15602021</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Jul 15;45(2):158-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17578773</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2007 Oct;28(20):2525-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17951287</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2008;(1):CD000422</Citation><ArticleIdList><ArticleId IdType="pubmed">18253977</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2008 Jul 15;47(2):182-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18533841</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2008 Oct 7;179(8):749-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18838444</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2008 Oct 7;179(8):773-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18838452</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2009 Jan 6;180(1):48-58</Citation><ArticleIdList><ArticleId IdType="pubmed">19124790</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2009 Feb 3;180(3):319; author reply 320</Citation><ArticleIdList><ArticleId IdType="pubmed">19188633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2010 Feb;10(2):83-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20113977</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2010;10:25</Citation><ArticleIdList><ArticleId IdType="pubmed">20085658</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 May 5;303(17):1699-706</Citation><ArticleIdList><ArticleId IdType="pubmed">20442385</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 May 5;303(17):1751-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20442393</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Aug 18;304(7):742; author reply 743</Citation><ArticleIdList><ArticleId IdType="pubmed">20716734</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 1;51(9):1007-16</Citation><ArticleIdList><ArticleId IdType="pubmed">20887208</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2010 Sep;36(3):608-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20075048</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2003 Jun;9(6):736-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12740573</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 1997 Apr 4;46(RR-8):1-24</Citation><ArticleIdList><ArticleId IdType="pubmed">9132580</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2006;6:231</Citation><ArticleIdList><ArticleId IdType="pubmed">16981982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="De Diego, Cinta" sort="De Diego, Cinta" uniqKey="De Diego C" first="Cinta" last="De Diego">Cinta De Diego</name><name sortKey="Gomez, Frederic" sort="Gomez, Frederic" uniqKey="Gomez F" first="Frederic" last="Gomez">Frederic Gomez</name><name sortKey="Gutierrez Perez, Antonia" sort="Gutierrez Perez, Antonia" uniqKey="Gutierrez Perez A" first="Antonia" last="Gutierrez-Perez">Antonia Gutierrez-Perez</name><name sortKey="Ochoa Gondar, Olga" sort="Ochoa Gondar, Olga" uniqKey="Ochoa Gondar O" first="Olga" last="Ochoa-Gondar">Olga Ochoa-Gondar</name><name sortKey="Raga, Xavier" sort="Raga, Xavier" uniqKey="Raga X" first="Xavier" last="Raga">Xavier Raga</name><name sortKey="Rodriguez Blanco, Teresa" sort="Rodriguez Blanco, Teresa" uniqKey="Rodriguez Blanco T" first="Teresa" last="Rodriguez-Blanco">Teresa Rodriguez-Blanco</name><name sortKey="Salsench, Elisabet" sort="Salsench, Elisabet" uniqKey="Salsench E" first="Elisabet" last="Salsench">Elisabet Salsench</name><name sortKey="Satue, Eva" sort="Satue, Eva" uniqKey="Satue E" first="Eva" last="Satue">Eva Satue</name><name sortKey="Vila Rovira, Angel" sort="Vila Rovira, Angel" uniqKey="Vila Rovira A" first="Angel" last="Vila-Rovira">Angel Vila-Rovira</name></noCountry><country name="Espagne"><noRegion><name sortKey="Vila Corcoles, Angel" sort="Vila Corcoles, Angel" uniqKey="Vila Corcoles A" first="Angel" last="Vila-Corcoles">Angel Vila-Corcoles</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000336 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000336 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22436146
|texte= Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22436146" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |